Skip to main content
Figure 5 | Lipids in Health and Disease

Figure 5

From: Lactobacillus gasseri SBT2055 suppresses fatty acid release through enlargement of fat emulsion size in vitro and promotes fecal fat excretion in healthy Japanese subjects

Figure 5

Effect of intake of FM containing Lactobacillus gasseri SBT2055 (LG2055) on fecal fat excretion in humans. (A) Fecal samples were collected during the final three days of the pre-observational period (before) and FM intake period (after), and fecal fat levels were determined. (B) The amount of change in the fecal fat levels in the control and active FM groups. Values were calculated by subtracting fecal fat levels at pre-observational period from those at FM intake period. Values are means with standard deviations. Statistical analysis was performed using paired Student’s t-test (A) and unpaired Student’s t-test (B). An asterisk indicates a significant difference (P < 0.05).

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X